Forum of Clinical Oncology (Oct 2023)
Re-Irradiation in Squamous Cell Carcinoma of the Head and Neck
Abstract
Re-irradiation as a therapeutic option for locoregional recurrence in patients with recurrent, persistent tumour or second primary malignant neoplasm has great advantages for locally advanced unresectable tumours.
Keywords